Showing items 1–100
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-11951181-B2
United States of America
Lipid nanoparticle compositions and methods for MRNA delivery
Grant US-11951180-B2
United States of America
Methods for purification of messenger RNA
Grant US-11884692-B2
United States of America
Modified RNA encoding VEGF-A polypeptides, formulations, and uses relating thereto
Grant US-11866475-B2
United States of America
Ribonucleic acid purification
Grant US-11845772-B2
United States of America
Methods for purification of messenger RNA
Grant US-11820977-B2
United States of America
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-11730825-B2
United States of America
Lipid nanoparticles for delivering modified RNA encoding a VEGF-A polypeptide
Grant US-11696892-B2
United States of America
Methods for purification of messenger RNA
Grant US-11692189-B2
United States of America
Methods for therapeutic administration of messenger ribonucleic acid drugs
Grant US-11590157-B2
United States of America
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
Grant US-11564998-B2
United States of America
Lipid nanoparticle compositions and methods for MRNA delivery
Grant US-11547764-B2
United States of America
CFTR MRNA compositions and related methods and uses
Grant US-11510937-B2
United States of America
RNA-coded antibody
Grant US-11421038-B2
United States of America
mRNA therapy for phenylketonuria
Grant US-11377642-B2
United States of America
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-11338044-B2
United States of America
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
Application EP-3978030-A1
European Patent Office
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-11291734-B2
United States of America
MODIFIED RNA ENCODING VEGF-A POLYPEPTIDES, FORMULATIONS, AND USES RELATING THERETO
Application EP-3971204-A1
European Patent Office
Codon-optimized CFTR MRNA
Grant US-11253605-B2
United States of America
Nuclease resistant polynucleotides and uses thereof
Grant US-11254936-B2
United States of America
MRNA therapy for argininosuccinate synthetase deficiency
Grant US-11224642-B2
United States of America
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-11185595-B2
United States of America
RNA-CODED ANTIBODY
Grant EP-3115064-B1
European Patent Office
Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
Grant US-11173190-B2
United States of America
Methods for purification of messenger RNA
Grant US-11174500-B2
United States of America
Method for changing the intercellular mobility of an mRNA
Grant US-11142771-B2
United States of America
MRNA for use in treatment of human genetic diseases
Grant US-11135274-B2
United States of America
Methods for purification of messenger RNA
Grant US-11059841-B2
United States of America
Multiplex Alteration of Cells Using a Pooled Nucleic Acid Library and Analysis Thereof
Application US-20210207131-A1
United States of America
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-11052159-B2
United States of America
METHODS AND COMPOSITIONS FOR DELIVERING MRNA CODED ANTIBODIES
Grant EP-2970456-B1
European Patent Office
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-10888626-B2
United States of America
Methods for purification of messenger RNA
Grant US-10876104-B2
United States of America
Methods for therapeutic administration of messenger ribonucleic acid drugs
Grant US-10849920-B2
United States of America
Polynucleotides encoding immune modulating polypeptides
Grant US-10815291-B2
United States of America
Modified Polynucleotides for the production of biologics and proteins associated with…
Grant US-10772975-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-10751386-B2
United States of America
Nucleic acid vaccines
Grant US-10709779-B2
United States of America
Modified polynucleotides for the production of secreted proteins
Grant US-10703789-B2
United States of America
Multi-indication mRNA cancer immunotherapy
Grant US-10682401-B2
United States of America
RNA-CODED ANTIBODY
Application EP-3636669-A1
European Patent Office
In vivo production of proteins
Grant US-10583203-B2
United States of America
Liver specific delivery of messenger RNA
Grant US-10576166-B2
United States of America
Modified polynucleotides for the production of secreted proteins
Grant US-10577403-B2
United States of America
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-10507249-B2
United States of America
Modified polynucleotides
Grant US-10501512-B2
United States of America
Modified polynucleotides for the production of oncology-related proteins and peptides
Application US-10501513-B2
United States of America
In vivo production of proteins
Application US-10493167-B2
United States of America
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
Application US-10463751-B2
United States of America
CFTR MRNA compositions and related methods and uses
Grant US-10420791-B2
United States of America
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-10413618-B2
United States of America
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH…
Application EP-3520821-A1
European Patent Office
IN VIVO PRODUCTION OF PROTEINS
Application EP-3520820-A1
European Patent Office
Lipid nanoparticle compositions and methods for mRNA delivery
Grant US-10350303-B1
United States of America
Method for changing the intercellular mobility of an mRNA
Application US-10351865-B2
United States of America
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
Application EP-3505176-A1
European Patent Office
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
Application EP-3501550-A1
European Patent Office
OPTIMISED INJECTION FORMULATION FOR MRNA
Grant EP-3153179-B1
European Patent Office
Polynucleotides encoding low density lipoprotein receptor
Grant US-10323076-B2
United States of America
Lipid nanoparticle compositions and methods for MRNA delivery
Grant US-10238754-B2
United States of America
MRNA therapy for phenylketonuria
Grant US-10208295-B2
United States of America
Methods for purification of messenger RNA
Grant US-10155785-B2
United States of America
Liver specific delivery of messenger RNA
Grant US-10143758-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-10064959-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-10022425-B2
United States of America
Nucleic acid vaccines
Grant US-10022435-B2
United States of America
RNA-CODED BISPECIFIC ANTIBODY
Application EP-3329941-A1
European Patent Office
Methods for purification of messenger RNA
Grant US-9957499-B2
United States of America
mRNA for use in treatment of human genetic diseases
Grant US-9956271-B2
United States of America
Delivery and formulation of engineered nucleic acids
Grant US-9950068-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9937233-B2
United States of America
Modified polynucleotides for the production of cosmetic proteins and peptides
Grant US-9878056-B2
United States of America
Nucleic acid vaccines
Grant US-9872900-B2
United States of America
Methods for purification of messenger RNA
Grant US-9850269-B2
United States of America
MODIFIED RNA ENCODING VEGF-A POLYPEPTIDES, FORMULATIONS, AND USES RELATING THERETO
Application WO-2017214175-A1
World Intellectual Property Organisation (WIPO)
Modified polynucleotides for the production of proteins
Grant US-9827332-B2
United States of America
Modified polynucleotides for the production of secreted proteins
Grant US-9828416-B2
United States of America
Modified polynucleotides for the production of biologics and proteins associated with…
Grant US-9814760-B2
United States of America
Modified polynucleotides for the production of proteins associated with human disease
Grant US-9782462-B2
United States of America
Pharmaceutical composition consisting of RNA having alkali metal as counter ion and…
Grant US-9771594-B2
United States of America
CFTR mRNA compositions and related methods and uses
Grant US-9713626-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9701965-B2
United States of America
Modified polynucleotides encoding hepatitis A virus cellular receptor 2
Grant US-9675668-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9657295-B2
United States of America
Pulmonary delivery of mRNA
Grant US-9597413-B2
United States of America
Terminally modified RNA
Grant US-9597380-B2
United States of America
Modified polynucleotides for the production of oncology-related proteins and peptides
Grant US-9587003-B2
United States of America
In vivo production of proteins
Application US-9572896-B2
United States of America
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
Grant US-9572897-B2
United States of America
RNA-CODED ANTIBODY
Application EP-3118224-A1
European Patent Office
RNA-CODED ANTIBODY
Application EP-3115064-A1
European Patent Office
Delivery and formulation of engineered nucleic acids
Grant US-9533047-B2
United States of America
MRNA therapy for phenylketonuria
Grant US-9522176-B2
United States of America
RNA-CODED ANTIBODY
Grant EP-2101823-B1
European Patent Office
Engineered nucleic acids and methods of use thereof
Grant US-9464124-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9447164-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9428535-B2
United States of America
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
Application EP-2834260-A4
European Patent Office
Showing items 1–100